These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Kafali G; Erselcan T; Tanzer F Clin Pediatr (Phila); 1999 Feb; 38(2):93-8. PubMed ID: 10047942 [TBL] [Abstract][Full Text] [Related]
23. Effects of lacosamide and carbamazepine on lipids in a randomized trial. Mintzer S; Dimova S; Zhang Y; Steiniger-Brach B; De Backer M; Chellun D; Roebling R Epilepsia; 2020 Dec; 61(12):2696-2704. PubMed ID: 33200428 [TBL] [Abstract][Full Text] [Related]
24. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Kim DW; Lee SY; Shon YM; Kim JH Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720 [TBL] [Abstract][Full Text] [Related]
25. Somatosensory evoked potentials in epileptic children treated with carbamazepine or valproate in monotherapy - a preliminary study. Sendrowski K; Sobaniec W; Boćkowski L; Kułak W; Smigielska-Kuzia J Adv Med Sci; 2010; 55(2):212-5. PubMed ID: 20513644 [TBL] [Abstract][Full Text] [Related]
26. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy]. Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847 [TBL] [Abstract][Full Text] [Related]
27. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study. Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483 [TBL] [Abstract][Full Text] [Related]
28. The effects of long-term anticonvulsive treatment on serum lipid profile. Yalçin E; Hassanzadeh A; Mawlud K Acta Paediatr Jpn; 1997 Jun; 39(3):342-5. PubMed ID: 9241897 [TBL] [Abstract][Full Text] [Related]
29. Thyroid hormone levels in children receiving carbamazepine or valproate. Aggarwal A; Rastogi N; Mittal H; Chillar N; Patil R Pediatr Neurol; 2011 Sep; 45(3):159-62. PubMed ID: 21824562 [TBL] [Abstract][Full Text] [Related]
30. Serum lipid levels during carbamazepine therapy in epileptic children. Mahmoudian T; Iranpour R; Messri N Epilepsy Behav; 2005 Mar; 6(2):257-9. PubMed ID: 15710313 [TBL] [Abstract][Full Text] [Related]
31. Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy. Yüksel A; Cengiz M; Seven M; Ulutin T J Basic Clin Physiol Pharmacol; 2000; 11(1):73-81. PubMed ID: 10851665 [TBL] [Abstract][Full Text] [Related]
32. Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital. Castro-Gago M; Novo-Rodríguez MI; Blanco-Barca MO; Urisarri-Ruíz de Cortázar A; Rodríguez-García J; Rodríguez-Segade S; Eirís-Puñal J J Child Neurol; 2006 Jan; 21(1):48-53. PubMed ID: 16551453 [TBL] [Abstract][Full Text] [Related]
33. Thyroid dysfunction associated with increased low-density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: a causal relationship? Attilakos A; Garoufi A; Voudris K; Mastroyianni S; Fotinou A; Papadimitriou DT; Gavalakis N; Prassouli A; Katsarou E Eur J Paediatr Neurol; 2007 Nov; 11(6):358-61. PubMed ID: 17428707 [TBL] [Abstract][Full Text] [Related]
34. Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children. Yuksel A; Senocak D; Sozuer D; Keskin G; Dirican A; Cenani A; Yalcin E Childs Nerv Syst; 1995 Aug; 11(8):474-7. PubMed ID: 7585685 [TBL] [Abstract][Full Text] [Related]
35. Effect of long-term carbamazepine therapy on serum lipids, vitamin B12 and folic acid levels in children. Deda G; Caksen H; Içağasioğlu D J Pediatr Endocrinol Metab; 2003 Feb; 16(2):193-6. PubMed ID: 12713256 [TBL] [Abstract][Full Text] [Related]
36. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666 [TBL] [Abstract][Full Text] [Related]
37. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Verrotti A; Basciani F; Domizio S; Sabatino G; Morgese G; Chiarelli F Pediatr Neurol; 1998 Nov; 19(5):364-7. PubMed ID: 9880141 [TBL] [Abstract][Full Text] [Related]
38. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Aycicek A; Iscan A Eur Neurol; 2007; 57(2):65-9. PubMed ID: 17179706 [TBL] [Abstract][Full Text] [Related]
39. Effect of carbamazepine therapy on serum lipids in children with partial epilepsy. Aggarwal A; Singh V; Batra S; Faridi MM; Sharma S Pediatr Neurol; 2009 Feb; 40(2):94-7. PubMed ID: 19135621 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of renal tubular function in children taking anti-epileptic treatment. Unay B; Akin R; Sarici SU; Gok F; Kurt I; Gokcay E Nephrology (Carlton); 2006 Dec; 11(6):485-8. PubMed ID: 17199783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]